Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02273882 · ClinicalTrials.gov registry record
An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 497
- Enrollment target
NCT02273882 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 497 participants.
The verdict
NCT02273882 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 497 participants
- Enrollment target
Study Summary
Purpose of this study is to evaluate clinical, humanistic and health economic burden of Respiratory Syncytial Virus (RSV) in infants born 29 to 35 Weeks Gestational Age (wGA) hospitalized for RSV at up to 12 months of age.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2014-11-17 |
| Est. Completion | 2016-08-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02273882
The ClinicalTrials.gov registry entry for NCT02273882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 497 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02273882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02273882 about?
NCT02273882 is a clinical study titled "An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants". Purpose of this study is to evaluate clinical, humanistic and health economic burden of Respiratory Syncytial Virus (RSV) in infants born 29 to 35 Weeks Gestational Age (wGA) hospitalized for RSV at up to 12 months of age.
What is the current status of trial NCT02273882?
This trial is currently completed. The enrollment target is 497 participants. The study started on 2014-11-17. Estimated completion is 2016-08-19.
Who is sponsoring clinical trial NCT02273882?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.